Printer Friendly

Cardiac function and intracellular [Ca.sup.2+] handling proteins are not impaired by high-saturated-fat diet-induced obesity.


The incidence and prevalence of obesity has increased worldwide, representing a pandemic and, consequently, a public health problem (1). Excess adiposity is strongly associated with increased mortality risk, reduction in life expectancy, and the development of major risk factors for numerous co-morbidities such as type II diabetes mellitus, hyperlipidemia, and cardiovascular diseases (2,3).

Current experimental studies with diet-induced obesity models focus not only on the amount of fat used but also on the source, resulting in diets with a predominance of saturated or unsaturated fatty acids, since they are substantially associated with different outcomes (4). In addition, research studies confirm that dietary saturated fatty acids are positively associated with increased ventricular remodeling, cardiac hypertrophy, and mitochondrial and contractile dysfunction (5-8).

The mechanisms responsible for functional abnormalities in obesity have not yet been fully clarified. Many factors have been presented as responsible for the cardiac changes in obesity, including intracellular calcium ([Ca.sup.2+] ) handling (9-12). The intracellular [Ca.sup.2+]-cycling proteins located in the sarcolemma and sarcoplasmic reticulum (SR), such as the L-type [Ca.sup.2+] channel, SR [Ca.sup.2+]ATPase (SERCA2a), phospholamban (PLB), calsequestrin (CSQ), ryanodine receptor (RYR), and Na+/[Ca.sup.2+] exchanger (NCX), are important in the regulation of myocardial contraction and relaxation by controlling calcium transient homeostasis (12,13). Thus, changes in proteins involved in coordinating [Ca.sup.2+] movement may contribute to contractile dysfunction.

Most studies found in the literature that assessed cardiac function and calcium handling-related proteins in obesity models used high-fat diets with a predominance of unsaturated fatty acids (9,14-18). However, Cheng et al. (19), using a high-fat diet rich in saturated fatty acids for 8 weeks, showed that only pPLB [Thr.sup.17]/PLB ratio was downregulated, without altering the cardiac function and the protein levels of SERCA2a, PLB, pPLB [Ser.sup.1]6, as well as the ratios of SERCA2a and pPLB [Ser.sup.16] to total PLB. There is no study that evaluated all proteins related to myocardial [Ca.sup.2+] handling in long-term obesity induced by high-fat diet with a predominance of saturated fatty acids. Therefore, the aim of this study was to test the hypothesis that this dietary model of obesity causes cardiac dysfunction resulting from alterations in the regulatory proteins of intracellular calcium homeostasis. Taken together, the results will contribute to the understanding of the mechanisms underlying the participation of this pathway in heart function during a prolonged period of obesity.

Material and Methods

Animals and experimental protocol

Sixty-day-old male Wistar rats were obtained from Anilab Animais de Laboratorio Criacao e Comercio (Paulinia, Brazil). After 7 days of acclimatization, the rats were randomized into two groups: control (C, n=18) and obese (Ob, n=19), which were fed a standard diet (SDiet) and a high-saturated-fat diet (HSFDiet), respectively, for 33 weeks. All rats had free access to food and water. The animals were housed in individual cages with controlled temperature (24 [+ or -] 2[degrees]C), humidity (55 [+ or -] 5%), and light (12-h light/dark cycle). The experimental protocol was approved by the Ethics Committee on Animal Experimentation of the Botucatu Medical School, UNESP (protocol no. 994/2012). All procedures were in accordance with the "Guide for the Care and Use of Laboratory Animals, 8th Edition" published by the U.S. National Research Council (20).


The diets were developed at the Experimental Research Unit (UNIPEX) of the Botucatu Medical School in partnership with Biotron Zootecnica[R] (Brazil), based on a dietary model previously used by the group (21). The following ingredients were used to formulate both diets: corn bran, soybean hulls and bran, dextrin, salt, vitamin and mineral complex, palm kernel oil, and soybean oil. The SDiet contained 31.0% of its kcal from protein, 51.6% from carbohydrates, and 17.4% from fat; the HSFDiet values were 18.7% from proteins, 41.6% from carbohydrates, and 39.7% from fat. The HSFDiet was calorically richer (HSFDiet=3.85 kcal/g vs SDiet=3.10 kcal/g) due to higher energy from fat. The content of saturated/unsaturated fatty acids was 61.5/38.5% in the SDiet and 64.8/ 35.2% in the HSFDiet.

Nutritional profile

The nutritional profile was evaluated according to the following parameters: food and calorie intake, feed efficiency, body weight, body fat, and adiposity index. Food intake and body weight of the animals were measured weekly. Calorie consumption was determined by multiplying the energy value of each diet (g x kcal) by the weekly food intake. To analyze the capacity of converting consumed food energy into body weight, feed efficiency was calculated by dividing the total body weight gain (g) by the total energy intake (kcal). The adipose tissue fat pads were dissected and weighed after the animals were anesthetized (50 mg/kg ketamine; 1 mg/kg xylazine; intraperitoneal injection [ip]; Sespo Industria e Comercio Ltda - Divisao Vetbrands, Brazil) and decapitated. Total body fat was determined by the sum of the epididymal, retroperitoneal, and visceral fat pads. The adiposity index was calculated by total body fat divided by the final body weight and multiplied by 100.

Obesity-related comorbidities

Systolic blood pressure (SBP). At the end of the experimental protocol, one week before euthanasia, SBP was measured in conscious rats using the non-invasive tail-cuff method with an electro-sphygmomanometer, Narco Bio-System (International Biomedical, USA). The animals were warmed in a wooden box between 38 and 40[degrees]C, the heat was generated by two incandescent lamps for 4 min to cause vasodilation of the tail artery. Then, they were transferred to an iron cylindrical support that was specially designed to allow total exposure of the tail. After this process, a sensor coupled to the electrosphygmomanometer was placed in the proximal region of the tail (22). The arterial pulsations were recorded in a computerized data acquisition system (Biopac Systems Inc., USA). On average, two readings were recorded for each measurement.

Metabolic and hormonal profile. The glucose tolerance test was performed one week before euthanasia. The animals were fasted for 6 hours and blood samples from the tail tip were collected at baseline and after intraperitoneal administration of 30% glucose solution, equivalent to 2.0 g/kg body weight. The samples were analyzed using a handheld glucometer (Accu-Chek Go Kit; Roche Diagnostica Brasil Ltda, Brazil) at baseline (0 min) and after 15, 30, 60, 90, and 120 min of glucose injection. Glucose tolerance was assessed by the area under the curve (AUC). At the end of the experimental protocol, the animals were fasted for 12 h, anesthetized (50 mg/kg ketamine; 1 mg/kg xylazine; ip; Sespo Industria e Comercio Ltda - Divisao Vetbrands), and euthanized by decapitation. Blood samples were collected, and the serum was separated by centrifugation at 1,620 g for 10 min at 4[degrees]C and stored at -80[degrees]C for later analysis. Triacylglycerol, total cholesterol, high-density lipoprotein (HDL), and low-density lipoprotein (LDL) concentrations were determined using specific kits (BIOCLIN[R], Brazil) in an automated chemical analyzer BS-200 (Mindray, China). The non-esterified fatty acids (NEFA) levels were evaluated using a colorimetric kit (WAKO Pure Chemical Industries Ltd, Japan). Leptin and insulin levels were analyzed by the enzyme-linked immunosorbent assay (ELISA) method (EMD Millipore Corporation, USA). For glucose analysis, the animals were exposed to fasting and anesthesia, as described above, and blood samples were collected from the tail tip; the glucose levels were assessed using a handheld glucometer. The homeostatic model assessment of insulin resistance (HOMA-IR) was used as an insulin resistance index, calculated according to the formula: HOMA-IR = [fasting glucose (mmol/L) x fasting insulin ([micro]U/mL)] / 22.5 (23).

Cardiac remodeling

Macroscopic analysis postmortem. Cardiac remodeling was evaluated by postmortem analysis of the following parameters: atria (A) and left (LV) and right (RV) ventricles weights, and their ratio with tibia length.

Echocardiographic evaluation. The echocardiographic study was performed one week before euthanasia using a commercially available echocardiography machine (General Electric Medical Systems, Vivid S6, Israel) equipped with a 5-11.5 MHz electronic transducer, as previously described (10,24). Briefly, the rats were anesthetized via ip injection of a mixture of

ketamine (50 mg/kg) and xylazine (1 mg/kg). A two-dimensional parasternal shortaxis view of the LV was obtained at the level of the papillary muscles. M-mode tracings were obtained from short-axis views of the LV at or just below the tip of the mitral valve leaflets, and at the level of the aortic valve and left atrium. M-mode images of the LV were printed on a black-and-white thermal printer (Sony UP-890MD, Japan) at a sweep speed of 100 mm/s. All cardiac structures were manually measured with a caliper by the same researcher, according to the method of the American Society of Echocardiography (25). Measurements were recorded as the mean of at least five consecutive cardiac cycles. The following LV structural parameters were evaluated: LV diastolic diameter (LVDD), LV diastolic posterior wall thickness (LVDPWT), LV relative wall thickness (LVRWT = 2 x LVDPWT / LVDD), and left atrium (LA) and aorta (AO) diameters. LV function was evaluated by the following parameters: heart rate (HR), endocardial fractional shortening (FS), posterior wall shortening velocity (PWSV), early and late diastolic mitral inflow velocities (E and A waves), and E/A ratio.

Isolated papillary muscle function. Cardiac contractile performance was evaluated by studying the isolated papillary muscle from the LV as previously described (10,16). The following mechanical parameters were measured from isometric contraction: maximum developed tension (DT; g/[mm.sup.2]), resting tension (RT; g/[mm.sup.2]), and peak of positive (+dT/dt; g/[mm.sup.2]/s) and negative (-dT/dt; g/[mm.sup.2]/s) tension derivatives. The mechanical behavior of the papillary muscle was evaluated under baseline conditions at 2.5 mM [Ca.sup.2+] and after inotropic and lusitropic maneuvers: length-tension relationship, increases in extracellular [Ca.sup.2+] concentrations (to test their effects on myofilament machinery), and post-rest contraction (PRC), mainly related to SR storage and release capacity. The length-tension relationships were characterized by determining the RT (myocardial stiffness) and DT (Frank-Starling curve) at baseline (100% [l.sub.max]), and 98, 96, 94, and 92% of optimum length. RT-length and DT-length curves were plotted using regression analysis: log(RT) = - 51.1118 + 25.5425 log([l.sub.max])for the C group; log(RT)= - 58.1992 + 29.1455 log([l.sub.max]) forthe Ob group; DT = 29.444 - 2349.613 / [l.sub.max] for the C group; DT = 29.232 2285.702 / [l.sub.max] for the Ob group. Inotropic responses were recorded 5 min after the addition of each dose of extracellular [Ca.sup.2+] (0.5, 1.0, 1.5, 2.0, and 2.5 mM) to the bathing solution. PRC was studied at an extracellular [Ca.sup.2+] concentration of 0.5 mM, the stimulus was paused for 10, 30, and 60 s before restarting the stimulation. During rest, the SR of rats accumulates a lot more [Ca.sup.2+] than what is accumulated during regular stimulation, and the first beat after the rest interval is stronger than the beat before the rest interval. All variables were normalized by the papillary muscle cross-sectional area.

Expression of myocardial calcium handling proteins. The following proteins were evaluated by western blot: SERCA2a, PLB, pPLB [Ser.sup.16], pPLB [Thr.sup.17], RYR, CSQ, NCX, and L-type [Ca.sup.2+] channel. Briefly, the LV samples were rapidly frozen in liquid nitrogen and subsequently homogenized in a solution containing RIPA buffer (Amresco LLC, USA) with protease (Sigma-Aldrich, USA) and phosphatase (Roche Diagnostics, USA) inhibitors. The protein samples extracted (50 [micro]g/lane) were subjected to 6-10% SDSpolyacrylamide gel electrophoresis (SDS-PAGE), depending on the molecular weight of the protein. The separated proteins were transferred to nitrocellulose membranes (Armsham Biosciences, USA) and blocked with 5% nonfat dry milk/TBST for 2 h at room temperature. The membranes were incubated overnight at 4[degrees]C with primary antibodies against SERCA2a (1:2,500; ABR Affinity BioReagents, USA), PLB (1:1,000, Abcam, USA), pPLB [Ser.sup.16] (1:5,000; Badrilla, UK), pPLB [Thr.sup.17] (1:5,000; Badrilla), RYR (1:5,000; ABR Affinity BioReagents), CSQ (1:300; ABR Affinity BioReagents), NCX (1:1,000; Upstate, USA), and L-type [Ca.sup.2+] channel alpha 1C (1:100; Chemicon International, USA). Then, the membranes were incubated with peroxidase-conjugated secondary antibodies (rabbit or mouse IgG, depending on the primary antibody) for 2 h at room temperature. The blots were detected using Enhanced Chemiluminescence Reagent (ECL, Amersham Biosciences, USA) and analyzed with Scion Image software (Scion Corporation, USA). Targeted bands were normalized to the expression of b-actin (1:1,000; Cell Signaling, USA).

Statistical analysis

Data are reported as means [+ or -] SD. Student's t-test was used to analyze the results for nutritional profile, comorbidities, cardiac macroscopic and echocardiographic parameters, papillary muscle function at baseline condition, and calcium handling proteins expression. The papillary muscle function after interventions was evaluated using analysis of variance (ANOVA) on the model of repeated measures for independent groups and complemented by the Bonferroni post hoc test for multiple comparisons when significant differences were found (P<0.05). The least squares method was used to adjust the linear regression models of DT as a function of the inverse of the length, and of the logarithm of the RT as a function of length for the control and obese groups. The procedure was complemented with statistical comparison of the equality of the models in the two study groups. For all analyses, P<0.05 was considered statistically significant.


Nutritional profile and comorbidities

Tables 1 and 2 show the nutritional profile and comorbidities of the animals after 33 weeks of treatment. The final body weight, weight gain, naso-anal length, epididymal, retroperitoneal and visceral fat deposits, total body fat, and adiposity index were higher in obese compared to control animals. Although the calorie consumption was similar in both groups and the food intake was lower in the obese animals, the feed efficiency was higher in the Ob group (Table 1).

Obesity caused significant metabolic and hormonal changes. The systolic blood pressure, AUC, HOMA-IR and triglycerides, total cholesterol, LDL, NEFA, glucose, insulin, and leptin serum levels were significantly higher in the Ob group compared to the C group (Table 2).

Postmortem cardiac macroscopic analysis

Tibia length (C: 4.22 [+ or -]0.12 vs Ob: 4.30 [+ or -]0.18 cm; P=0.16) and the LV/tibia (C: 0.18 [+ or -] 0.02 vs Ob: 0.18 [+ or -] 0.01 g/cm; P=0.94) and RV/tibia (C: 0.05 [+ or -] 0.01 vs Ob: 0.05 [+ or -] 0.02 g/cm; P=0.90) ratios were not statistically different between the groups. The atrium/tibia ratio (C: 0.019 [+ or -]0.003 vs Ob: 0.021 [+ or -] 0.004 g/cm; P=0.04) was greater in the Ob compared to the C group.

Echocardiographic evaluation

Structural and functional echocardiographic data are shown in Table 3. The LVDPWT, LA, and LA/AO were significantly higher in Ob rats; there was no difference in other structural parameters. The systolic function was similar between C and Ob groups, except for PWSV, which was greater in obese rats. The diastolic function parameters had no difference between groups.

Papillary muscle function

Figures 1, 2, 3, and 4 summarize the mechanical properties of the isolated papillary muscle of obese and control rats, from the baseline condition and after inotropic intervention. Obesity did not cause contractile dysfunction at baseline condition (Figure 1). The influence of muscular length variation over resting tension and developed tension was similar in both groups (Figure 2). Although the inotropic maneuvers promoted intragroup changes, no differences were observed between groups with increased extracellular [Ca.sup.2+] concentrations and post-rest contraction, suggesting that intracellular [Ca.sup.2+] homeostasis was not compromised in obese rats (Figure 3 and 4).

Protein expression of myocardial calcium handling

Results from intracellular [Ca.sup.2+] cycling proteins SERCA2a, PLB, pPLB Ser16, pPLB Thr17, RYR, CSQ, NCX, and L-type [Ca.sup.2+] channel are summarized in Figure 5 and 6. Data showed that the expression of these proteins was unchanged by the high-fat diet (Figure 5). Furthermore, the ratios of SERCA2a/PLB, pPLB Ser16/PLB, and pPLB Thr17/PLB were similar in both groups (Figure 6).


The aim of this study was to investigate whether obesity promotes cardiac dysfunction due to changes in the expression of myocardial regulatory proteins of intracellular calcium homeostasis. The results showed that the excess adipose tissue did not lead to functional cardiac injury nor impaired the proteins related to intracellular [Ca.sup.2+] handling.

Obesity has been extensively studied in experimental models to identify the molecular mechanisms involved in pathological cardiac remodeling. For this purpose, different models with high-fat diets have been used. In this study, a high-fat diet with predominance of saturated fatty acids was used, which was efficient to increase the body weight (16%) and adiposity index (104%) of the rats, corroborating other authors (26,27). These changes occurred despite the lower food intake and similar calorie intake of obese animals compared to controls. According to the literature, saturated fatty acids are usually less oxidized than unsaturated ones; in addition, fat thermogenesis is lower than other nutrients, such as carbohydrates and proteins, thus favoring fat deposition (28-30).

Obese animals presented numerous comorbidities, such as increased blood pressure, glucose intolerance, insulin resistance, dyslipidemia, hyperinsulinemia, and hyperleptinemia, which are found in obese patients with metabolic syndrome (31 -33).

Cardiac postmortem morphological analysis showed that these animals presented atrial hypertrophy and did not develop left ventricular remodeling. Structural echocardiographic assessment showed increased left atrial diameter, likely related to hypervolemia or diastolic dysfunction that occur in obesity (34,35).

The proposal of this research was to evaluate the effects of obesity on cardiac function and [Ca.sup.2+] handlingrelated myocardial proteins. The functional echocardiographic evaluation did not show diastolic dysfunction and revealed change in systolic function by increased PWSV in obese animals, showing that the improvement in myocardial contractility was probably a consequence of adrenergic hyperactivity due to higher leptin, insulin, and fatty acids circulating levels (36,37). The functional study of the isolated papillary muscle detected no difference between the groups at baseline and after inotropic maneuvers that evaluated the calcium participation on myocardium function. This difference in data found between both methods, i.e., echocardiography and papillary muscle, is probably because the heart, in vivo, is influenced by the neurohumoral system, which is exacerbated in obesity, which does not occur in the in vitro preparation. In addition, the papillary muscle analysis assessed strength parameters, while the echocardiogram assessed the wall movement. One possible factor that may have limited the detection of cardiac dysfunction by echocardiogram in this study can be attributed to the functional evaluation methods of the heart. Perhaps performing the tissue Doppler imaging for myocardial velocities or strain imaging could show additional information. Furthermore, measuring the left ventricular pressure may be helpful to show changes in diastolic function. Therefore, in disagreement with our hypothesis, high-saturated-fat diet-induced obesity did not cause cardiac dysfunction, in agreement with other authors (5,19,27).

Regarding the myocardial proteins analysis related to the intracellular [Ca.sup.2+] handling, obesity did not induce significant changes in the molecules analyzed. Most of the studies found in the literature on this subject used models of obesity induced by high-fat diets rich in unsaturated fatty acids and the results are divergent, probably due to differences in experimental protocols (9,14-18,32). As mentioned previously, Cheng et al. (19), using a high-saturated-fat diet in male Wistar rats for 8 weeks, showed that only pPLB Thr17/PLB ratio was downregulated, despite no evidence of left ventricular dysfunction or remodeling. This finding regarding the pPLB Thr17/PLB ratio is in disagreement with our results, since none of the protein expressions changed, possibly due to the period of dietary treatment or, more likely, due to the source and percentage of dietary fatty acids. The chosen fat source in the present study was mainly palm kernel oil, which is a vegetable source; therefore, it may contain protective compounds despite being predominantly saturated. Fat from animal sources, like the lard used by Cheng et al. (19), is more often associated with harmful health outcomes (38).

A limitation of this study might be the sample size, since it was not possible to perform the cardiac functional analysis in all animals due to technical problems (e.g., poor image, high heart beat, etc.) in echocardiogram and methodological issues (e.g., similar cross-sectional area between the groups) in the papillary muscle study. This limiting factor might interfere in the power of statistical analysis and consequently in the cardiac function outcomes found in the present study. Despite the fact that the appropriate sample size for basic science research could be a particular challenge, the sample size used in this study was in accordance with several other studies (9,16,19,39,40).

In conclusion, our hypothesis was rejected, because obesity induced by the high-saturated-fat diet was not effective in triggering cardiac dysfunction and impairing the proteins related to intracellular [Ca.sup.2+] handling. Further studies in dietary obesity models that result in cardiac dysfunction are required to better clarify the role of the proteins involved in myocardial [Ca.sup.2+] handling on the impairment of heart performance caused by obesity.


This research was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2012/20733-0). The authors are grateful to Maria R. Moretto, Mario B. Bruno (in memorian), Antonio C. de Lalla, and Ana Paula D. P. da Cruz for their technical assistance.


(1.) World Health Organization. Fact sheets: Obesity and overweight. http: // obesity-and-overweight. Accessed July 30, 2018.

(2.) Malnick SDH, Knobler H. The medical complications of obesity. QJM 2006; 99: 565-579, doi: 10.1093/qjmed/ hcl085.

(3.) Stein CJ, Colditz GA. The epidemic of obesity. J Clin Endocrinol Metab 2004; 89: 2522-2525, doi: 10.1210/ jc.2004-0288.

(4.) Halade GV, Jin YF, Lindsey ML. Roles of saturated vs. polyunsaturated fat in heart failure survival: not all fats are created equal. Cardiovasc Res 2012; 93: 4-5, doi: 10.1093/ cvr/cvr298.

(5.) Okere IC, Chandler MP, McElfresh TA, Rennison JH, Sharov V, Sabbah HN, et al. Differential effects of saturated and unsaturated fatty acid diets on cardiomyocyte apoptosis, adipose distribution, and serum leptin. Am J Physiol Heart Circ Physiol 2006; 291: H38-H44, doi: 10.1152/ajpheart. 01295.2005.

(6.) Jeckel KM, Miller KE, Chicco AJ, Chapman PL, Mulligan CM, Falcone PH, et al. The role of dietary fatty acids in predicting myocardial structure in fat-fed rats. Lipids Health Dis 2011; 10: 92, doi: 10.1186/1476-511X-10-92.

(7.) Schaffer JE. Lipotoxicity: when tissues overeat. Curr Opin Lipidol 2003; 14: 281-287, doi: 10.1097/00041433-2003060 00-00008.

(8.) Sharma N, Okere IC, Duda MK, Chess DJ, O'shea KM, Stanley WC. Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy. Cardiovasc Res 2007; 73: 257-268, doi: 10.1016/j.cardiores.2006.11.007.

(9.) Lima-Leopoldo AP, Leopoldo AS, da Silva DC, do Nascimento AF, de Campos DHS, Luvizotto RAM, et al. Longterm obesity promotes alterations in diastolic function induced by reduction of phospholamban phosphorylation at serine-16 without affecting calcium handling. J Appl Physiol 2014; 117: 669-678, doi: 10.1152/japplphysiol. 00088.2014.

(10.) Leopoldo AS, Sugizaki MM, Lima-Leopoldo AP, do Nascimento AF, Luvizotto R de AM, de Campos DHS, et al. Cardiac remodeling in a rat model of diet-induced obesity. Can J Cardiol2010; 26: 423-429, doi: 10.1016/S0828-282X (10)70440-2.

(11.) Ren J, Zhu BH, Relling DP, Esberg LB, Ceylan-Isik AF. Highfat diet-induced obesity leads to resistance to leptin-induced cardiomyocyte contractile response. Obesity (Silver Spring) 2008;16: 2417-2423, doi: 10.1038/oby.2008.381.

(12.) Paulino EC, Ferreira JCB, Bechara LR, Tsutsui JM, Mathias W, Lima FB, et al. Exercise training and caloric restriction prevent reduction in cardiac [Ca.sup.2+]-handling protein profile in obese rats. Hypertension 2010; 56: 629-635, doi: 10.1161/HYPERTENSIONAHA.110.156141.

(13.) Bers DM. Cardiac excitation-contraction coupling. Nature 2002; 415: 198-205, doi: 10.1038/415198a.

(14.) Relling DP, Esberg LB, Fang CX, Johnson WT, Murphy EJ, Carlson EC, et al. High-fat diet-induced juvenile obesity leads to cardiomyocyte dysfunction and upregulation of Foxo3a transcription factor independent of lipotoxicity and apoptosis. J Hypertens 2006; 24: 549-561, doi: 10.1097/01. hjh.0000203846.34314.94.

(15.) Turdi S, Hu N, Ren J. Tauroursodeoxycholic acid mitigates high fat diet-induced cardiomyocyte contractile and intracellular [Ca.sup.2+] anomalies. PLoS One 2013; 8: e63615, doi: 10.1371/journal.pone.0063615.

(16.) Leopoldo AS, Lima-Leopoldo AP, Sugizaki MM, do Nascimento AF, de Campos DHS, Luvizotto R de AM, et al. Involvement of L-type calcium channel and SERCA2a in myocardial dysfunction induced by obesity. J Cell Physiol 2011; 226: 2934-2942, doi: 10.1002/jcp.22643.

(17.) Sahraoui A, Dewachter C, de Medina G, Naeije R, Aouichat Bouguerra S, Dewachter L. Myocardial structural and biological anomalies induced by high fat diet in psammomys obesus gerbils. PLoS One 2016; 11: e0148117, doi: 10.1371/ journal.pone.0148117.

(18.) Abdurrachim D, Ciapaite J, Wessels B, Nabben M, Luiken JJ, Nicolay K, et al. Cardiac diastolic dysfunction in highfat diet fed mice is associated with lipotoxicity without impairment of cardiac energetics in vivo. Biochim Biophys Acta 2014; 1842: 1525-1537, doi: 10.1016/j.bbalip.2014. 07.016.

(19.) Cheng Y, Li W, McElfresh TA, Chen X, Berthiaume JM, Castel L, et al. Changes in myofilament proteins, but not [Ca.sup.2+] regulation, are associated with a high-fat diet-induced improvement in contractile function in heart failure. Am J Physiol Heart Circ Physiol 2011; 301: H1438-H1446, doi: 10.1152/ajpheart.00440.2011.

(20.) National Research Council. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington (DC): National Academies Press (US); 2011.

(21.) Nascimento AF, Sugizaki MM, Leopoldo AS, Lima-Leopoldo AP, Luvizotto RAM, Nogueira CR, et al. A hypercaloric pellet-diet cycle induces obesity and co-morbidities in wistar rats. Arq Bras Endocrinol Metabol 2008; 52: 968-974, doi: 10.1590/S0004-27302008000600007.

(22.) Santos PP dos, Rafacho BPM, Goncalves A de F, Jaldin RG, Nascimento TB, Silva MAB, et al. Vitamin D induces increased systolic arterial pressure via vascular reactivity and mechanical properties. PLoS One 2014; 9: e98895, doi: 10.1371/journal.pone.0098895.

(23.) Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419, doi: 10.1007/BF00280883.

(24.) Gimenes C, Gimenes R, Rosa CM, Xavier NP, Campos DHS, Fernandes AAH, et al. Low intensity physical exercise attenuates cardiac remodeling and myocardial oxidative stress and dysfunction in diabetic rats. J Diabetes Res 2015; 2015: 457848, doi: 10.1155/2015/457848.

(25.) Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiograph. J Am Soc Echocardiogr 2005; 18: 1440-1463, doi: 10.1016/ j.echo.2005.10.005.

(26.) Buettner R, Parhofer KG, Woenckhaus M, Wrede CE, KunzSchughart LA, Scholmerich J, et al. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol 2006; 36: 485-501, doi: 10.1677/ jme.1.01909.

(27.) Vileigas DF, de Deus AF, da Silva DCT, de Tomasi LC, de Campos DHS, Adorni CS, et al. Saturated high-fat diet-induced obesity increases adenylate cyclase of myocardial b-adrenergic system and does not compromise cardiac function. Physiol Rep 2016; 4: e12914, doi: 10.14814/ phy2.12914.

(28.) Casas-Agustench P, Lopez-Uriarte P, Bullo M, Ros E, Gomez-Flores A, Salas-Salvado J. Acute effects of three high-fat meals with different fat saturations on energy expenditure, substrate oxidation and satiety. Clin Nutr 2009; 28: 39-45, doi: 10.1016/j.clnu.2008.10.008.

(29.) Krishnan S, Cooper JA. Effect of dietary fatty acid composition on substrate utilization and body weight maintenance in humans. Eur J Nutr 2014; 53: 691-710, doi: 10.1007/ s00394-013-0638-z.

(30.) Jequier E. Pathways to obesity. Int J Obes Relat Metab Disord 2002; 26: S12-S17, doi: 10.1038/sj.ijo.0802123.

(31.) Huang BW, Chiang MT, Yao HT, Chiang W. The effect of high-fat and high-fructose diets on glucose tolerance and plasma lipid and leptin levels in rats. Diabetes Obes Metab 2004; 6: 120-126, doi: 10.1111/j.1462-8902.2004.00323.x.

(32.) Freire PP, Alves CAB, Deus AF de, Leopoldo APL, Leopoldo AS, Silva DCT, et al. Obesity does not lead to imbalance between myocardial phospholamban phosphorylation and dephosphorylation. Arq Bras Cardiol 2014; 24: 1639-1641, doi: 10.5935/abc.20140083.

(33.) Dobrian AD, Davies MJ, Prewitt RL, Lauterio TJ. Development of hypertension in a rat model of diet-induced obesity. Hypertension 2000; 35: 1009-1015, doi: 10.1161/01.HYP. 35.4.1009.

(34.) Movahed MR, Saito Y. Obesity is associated with left atrial enlargement, E/A reversal and left ventricular hypertrophy. Exp Clin Cardiol 2008; 13: 89-91.

(35.) Abel ED, Litwin SE, Sweeney G. Cardiac remodeling in obesity. Physiol Rev 2008; 88: 389-419, doi: 10.1152/ physrev.00017.2007.

(36.) Pathak A, Smih F, Galinier M, Verwaerde P, Rouet P, PhilipCouderc P, et al. Insulin downregulates M(2)-muscarinic receptors in adult rat atrial cardiomyocytes: a link between obesity and cardiovascular complications. Int J Obes (Lond) 2005; 29: 176-182.

(37.) Lambert GW, Straznicky NE, Lambert EA, Dixon JB, Schlaich MP Sympathetic nervous activation in obesity and the metabolic syndrome--causes, consequences and therapeutic implications. Pharmacol Ther 2010; 126: 159-172, doi: 10.1016/j.pharmthera.2010.02.002.

(38.) Kubant R, Poon AN, Sanchez-Hernandez D, Domenichiello AF, Huot PS, Pannia E, et al. A comparison of effects of lard and hydrogenated vegetable shortening on the development of high-fat diet-induced obesity in rats. Nutr Diabetes 2015; 5: e188, doi: 10.1038/nutd.2015.40.

(39.) Bregagnollo EA, Zornoff LA, Okoshi K, Sugizaki M, Mestrinel MA, Padovani CR, et al. Myocardial contractile dysfunction contributes to the development of heart failure in rats with aortic stenosis. Int J Cardiol 2007;117: 109-114, doi: 10.1016/j.ijcard.2006.06.006.

(40.) Rosa CM, Gimenes R, Campos DH, Guirado GN, Gimenes C, Fernandes AA, et al. Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus. Cardiovasc Diabetol 2016; 15: 126, doi: 10.1186/s12933-016-0442-1.

A.F. Deus (iD), [1] D.F. Vileigas (iD) [1], D.C.T. Silva (iD) [1], L.C. Tomasi (iD) [1], D.H.S. Campos (iD) [1], K. Okoshi (iD) [1], C.R. Padovani (iD) [2], and A.C. Cicogna (iD) [1]

[1] Departamento de Clinica Medica, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, SP, Brasil

[2] Departamento de Bioestatistica, Instituto de Biociencias de Botucatu, Universidade Estadual Paulista, Botucatu, SP, Brasil

Correspondence: A.C. Cicogna: <>

Received September 24, 2018 | Accepted April 2, 2019

doi: 10.1590/1414-431X20198085

Caption: Figure 1. Basal evaluation of myocardial function in papillary muscles from control (n=11) and obese (n=11) rats. A, DT: maximum developed tension; B, RT: resting tension; C, +dT/dt: peak of positive tension derivatives; D, -dT/dt: peak of negative tension derivatives. Data are reported as means [+ or -] SD. Student's t-test for independent samples was used to compare data.

Caption: Figure 2. The relationship between muscle length and (A) resting tension and (B) developed tension from control (n=11) and obese (n=11) rats, using the progression model adjusted according to the group.

Caption: Figure 3. Effects of increased calcium concentration on myocardial function in papillary muscles from control (white bars; n=11) and obese (black bars; n=11) rats after 33 weeks. A, DT: maximum developed tension; B, RT: resting tension; C, + dT/dt: peak of positive tension derivatives; D, -dT/dt: peak of negative tension derivatives. Data are reported as means [+ or -] SD. * P<0.05 vs basal; # P<0.05 vs basal and 1.0 mM calcium (ANOVA and Bonferroni).

Caption: Figure 4. Effects of post-rest contraction on myocardial function in papillary muscles from control (white bars; n=11) and obese (black bars; n=11) rats after 33 weeks. A, DT: maximum developed tension; B, RT: resting tension; C, +dT/dt: peak of positive tension derivatives; D, -dT/dt: peak of negative tension derivatives. Data are reported as means [+ or -] SD. * P<0.05 vs basal; # P<0.05 vs basal and 10 s; & P<0.05 vs basal, 10 and 30 s (ANOVA and Bonferroni).

Caption: Figure 5. Western blot analysis of intracellular [Ca.sup.2+]-cycling proteins in myocardium from control (C, white bars) and obese (Ob, black bars) rats (n=6 in each group). A, Quantification of sarcoplasmic reticulum [Ca.sup.2+]-ATPase (SERCA2a), phospholamban (PLB), PLB serine-16 phosphorylation (pPLB Ser16), PLB threonine-17 phosphorylation (pPLB [Thr.sup.17]), ryanodine receptor (RYR), calsequestrin (CSQ), [Na.sup.+]/[Ca.sup.2+] exchanger (NCX), and L-type [Ca.sup.2+] channel. B, Representative bands of proteins evaluated by western blot. Data are reported as means [+ or -] SD. Student's t-test for independent samples was used to compare data.

Caption: Figure 6. Quantification of sarcoplasmic reticulum [Ca.sup.2+]-ATPase (SERCA2a), phospholamban (PLB), serine-16 phosphorylation (pPLB [Ser.sup.16]), and PLB threonine-17 phosphorylation (pPLB [Thr.sup.17]) normalized to PLB. Control: white bars; Obese: black bars (n=6 in each group). Data are reported as means [+ or -] SD. Student's t-test for independent samples was used to compare data.
Table 1. Nutritional profile.

                            Control (n=18)         Obese (n=19)

Initial body weight (g)     167 [+ or -] 14       167 [+ or -] 15
Final body weight (g)       467 [+ or -] 52       541 [+ or -] 68
Naso-anal length (cm)       27.3 [+ or -] 0.9      27.8 [+ or -] 0.7
Epididymal fat (g)          7.42 [+ or -] 3.03     15.5 [+ or -] 4.0
Retroperitoneal fat (g)     7.66 [+ or -] 3.58     21.8 [+ or -] 6.8
Visceral fat (g)            5.52 [+ or -] 2.16     11.4 [+ or -] 3.7
Total body fat (g)          20.6 [+ or -] 8.2      48.7 [+ or -] 13.3
Adiposity index (%)         4.52 [+ or -] 1.42     9.22 [+ or -] 1.54
Food intake (g/day)         24.2 [+ or -] 2.1      19.8 [+ or -] 1.9
Calorie intake (kcal/day)   71.3 [+ or -] 6.2      72.1 [+ or -] 6.9
Feed efficiency (%)         1.38 [+ or -] 0.16     1.72 [+ or -] 0.19


Initial body weight (g)     <0.001
Final body weight (g)       <0.001
Naso-anal length (cm)       0.03
Epididymal fat (g)          <0.001
Retroperitoneal fat (g)     <0.001
Visceral fat (g)            <0.001
Total body fat (g)          <0.001
Adiposity index (%)         <0.001
Food intake (g/day)         <0.001
Calorie intake (kcal/day)   0.69
Feed efficiency (%)         <0.001

Data are reported as means [+ or -] SD.
Student's t-test for independent samples was used.

Table 2. Obesity-related parameters.

                            Control (n=18)         Obese (n=19)

SBP (mmHg)                  121 [+ or -] 10        129 [+ or -] 67
Insulin (ng/mL) *           4.46 [+ or -] 1.38     6.07 [+ or -] 2.27
Leptin (ng/mL) *            3.58 [+ or -] 2.16     16.89 [+ or -] 5.90
AUC (mg x [dL.sup.-1]       18387 [+ or -] 3955    24356 [+ or -] 4640
   x min)
Homa-IR *                   29.3 [+ or -] 11.0     42.9 [+ or -] 19.0
Glucose (mg/dL)             104 [+ or -] 12        114 [+ or -]  12
Triacylglycerol (mg/dL)     46.7 [+ or -] 18.2     72.7 [+ or -] 25.4
Total cholesterol (mg/dL)   68.0 [+ or -] 13.4     78.2 [+ or -] 14.5
HDL (mg/dL)                 25.1 [+ or -] 3.9      27.1 [+ or -] 4.7
LDL (mg/dL)                 24.0 [+ or -] 4.3      27.7 [+ or -] 5.4
NEFA (mmol/L) *             0.42 [+ or -] 0.08     0.51 [+ or -] 0.11


SBP (mmHg)                  0.009
Insulin (ng/mL) *           0.03
Leptin (ng/mL) *            <0.001
AUC (mg x [dL.sup.-1]       <0.001
   x min)
Homa-IR *                   0.02
Glucose (mg/dL)             0.01
Triacylglycerol (mg/dL)     0.001
Total cholesterol (mg/dL)   0.04
HDL (mg/dL)                 0.17
LDL (mg/dL)                 0.03
NEFA (mmol/L) *             0.02

Data are reported as means [+ or -] SD. Student's t-test for
independent samples was used. SBP: systolic blood pressure; AUC:
area under the curve for glucose; HOMA-IR: homeostasis model
assessment of insulin resistance; HDL: high-density lipoprotein;
LDL: low-density lipoprotein; NEFA: non-esterified fatty acids. *
n=14 for C and n=15 for Ob.

Table 3. Echocardiographic evaluation.

                            Control (n=13)         Obese (n=11)

Heart rate (bpm)            261 [+ or -] 45        237 [+ or -] 23
LVDD (mm)                   7.55 [+ or -] 0.54     7.75 [+ or -] 0.46
LVDPWT                      1.36 [+ or -] 0.05     1.42 [+ or -] 0.09
LVRWT                       0.36 [+ or -] 0.02     0.37 [+ or -] 0.04
LA (mm)                     5.05 [+ or -] 0.42     5.47 [+ or -] 0.53
LA/AO                       1.28 [+ or -] 0.08     1.37 [+ or -] 0.11
FS (%)                      51.7 [+ or -] 4.2      53.9 [+ or -] 5.2
PWSV (mm/s)                 36.7 [+ or -] 3.4      41.8 [+ or -] 3.8
E wave (cm/s)               66.8 [+ or -] 6.5      71.2 [+ or -] 7.1
A wave (cm/s)               42.0 [+ or -] 7.5      43.5 [+ or -] 9.0
E/A                         1.63 [+ or -] 0.25     1.68 [+ or -] 0.25


Heart rate (bpm)            0.129
LVDD (mm)                   0.328
LVDPWT                      0.036
LVRWT                       0.585
LA (mm)                     0.041
LA/AO                       0.021
FS (%)                      0.254
PWSV (mm/s)                 0.002
E wave (cm/s)               0.134
A wave (cm/s)               0.670
E/A                         0.621

Data are reported as means [+ or -] SD. Student's t-test for
independent samples was used. LVDD: left ventricle diastolic
diameter; LVDPWT: left ventricle diastolic posterior wall
thickness; LVRWT: left ventricle relative wall thickness; LA: left
atrial diameter; AO: aortic diameter; FS: endocardial fractional
shortening; PWSV: posterior wall shortening velocity; E: early
diastolic mitral inflow velocity; A: late diastolic mitral inflow
COPYRIGHT 2019 Associacao Brasileira de Divulgacao Cientifica (ABDC)
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Article
Author:Deus, A.F.; Vileigas, D.F.; Silva, D.C.T.; Tomasi, L.C.; Campos, D.H.S.; Okoshi, K.; Padovani, C.R.;
Publication:Brazilian Journal of Medical and Biological Research
Geographic Code:3BRAZ
Date:Jun 1, 2019
Previous Article:Moderate-intensity exercise allows enhanced protection against oxidative stress-induced cardiac dysfunction in spontaneously hypertensive rats.
Next Article:Transcriptional profiling of uterine leiomyoma rats treated by a traditional herb pair, Curcumae rhizoma and Sparganii rhizoma.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |